The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
MOUNJARO Eli Lilly Australia Pty Ltd
Product name
MOUNJARO
Sponsor
Accepted date
Sep-2024
Active ingredients
tirzepatide
Proposed indication
Treatment of moderate to severe obstructive sleep
apnoea (repeated stopping and starting of breathing during sleep) in adults with obesity.
apnoea (repeated stopping and starting of breathing during sleep) in adults with obesity.
Application type
C (new indication)
Publication date
Sep-2024